Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T...

Area of Science:

• Immunology
• Cell Biology
• Biotechnology

Background:

• Cytotoxic T lymphocytes (CTLs) targeting minor histocompatibility antigens (mHags) are crucial for treating leukemia relapse post-allogeneic stem cell transplantation.
• Expanding these CTLs to therapeutic levels is challenging due to the scarcity of antigen-presenting cells (APCs).

Purpose of the Study:

• To investigate artificial antigen-presenting cells (aAPCs) as a substitute for professional APCs in expanding mHag-specific CTLs.
• To evaluate the efficacy of latex beads coated with HLA/mHag complexes and co-stimulatory molecules.

Main Methods:

• Cell-sized latex beads were coated with HLA-A2/HA-1 or HLA-A2/HA-2 complexes and recombinant CD80 and CD54 molecules.
• These aAPCs were used to stimulate HA-1- and HA-2-specific CTL clones and polyclonal CTL lines.
• CTL expansion, cytokine production, cytotoxic activity, and phenotype were assessed.

Main Results:

• aAPCs successfully stimulated HA-1- and HA-2-specific CTL clones, demonstrating ligand-specific expansion, cytokine release, and preserved cytotoxic function.
• CTL phenotype remained unaltered after stimulation with aAPCs.
• Polyclonal HA-1-specific CTL lines were enriched using aAPCs as effectively as with dendritic cells.

Conclusions:

• aAPCs coated with HLA/mHag complexes, CD80, and CD54 are effective tools for in vitro enrichment of mHag-specific CTLs.
• This approach offers a viable strategy for generating therapeutic CTL numbers for adoptive immunotherapy.
• aAPCs represent a scalable and efficient alternative to traditional APCs in immunotherapy development.